Adriakaim Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $4.31M

  • Investors
  • 9

Adriakaim General Information

Description

Developer of a nerve stimulation device designed to reduce the transition to chronic heart failure in patients. The company's device offers various treatment methods that utilize the parasympathetic nervous system in conjunction with the human body's natural healing capacities, enabling doctors to stimulate the vagus nerve and reduce the area of myocardial infarction.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 101, Hachioji Textile Center Building
  • 13-1 Minami-Shinmachi, Hachioji
  • Tokyo, 192-0075
  • Japan
+81
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Vertical(s)
Corporate Office
  • 101, Hachioji Textile Center Building
  • 13-1 Minami-Shinmachi, Hachioji
  • Tokyo, 192-0075
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Adriakaim Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series B) 15-Jun-2023 $4.31M Completed Generating Revenue
6. Early Stage VC 13-Sep-2021 Completed Generating Revenue
5. Early Stage VC 04-Aug-2020 Completed Generating Revenue
4. Early Stage VC 18-Nov-2019 Completed Generating Revenue
3. Seed Round 25-Feb-2019 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2019 Completed Startup
1. Accelerator/Incubator 01-Jan-2019 Completed Startup
To view Adriakaim’s complete valuation and funding history, request access »

Adriakaim Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
C Preferred Shares
B Preferred Shares
A Preferred Shares 2,510 $455.84 $455.84 1x $455.84 9.82%
To view Adriakaim’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Adriakaim Patents

Adriakaim Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2021112506-A Nerve stimulation apparatus and nerve stimulation method Pending 21-Jan-2020
US-20210220648-A1 Nerve stimulation apparatus and nerve stimulation method Inactive 21-Jan-2020
US-20130238057-A1 Nerve stimulating device Active 28-Oct-2010
US-20130110208-A1 Electrostimulation system, and electrostimulation electrode assembly and biological implantable electrode therefore Active 19-Mar-2010
US-9050453-B2 Electrostimulation system, and electrostimulation electrode assembly and biological implantable electrode therefore Active 19-Mar-2010 A61N1/05
To view Adriakaim’s complete patent history, request access »

Adriakaim Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Adriakaim Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Capital Medica Ventures Corporate Venture Capital Minority
FLAG-41 Venture Capital Minority
Screen Holdings Holding Company Minority
360ip Japan Venture Capital Minority
CEJ Capital Corporate Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Adriakaim FAQs

  • When was Adriakaim founded?

    Adriakaim was founded in 2018.

  • Where is Adriakaim headquartered?

    Adriakaim is headquartered in Tokyo, Japan.

  • What is the size of Adriakaim?

    Adriakaim has 10 total employees.

  • What industry is Adriakaim in?

    Adriakaim’s primary industry is Therapeutic Devices.

  • Is Adriakaim a private or public company?

    Adriakaim is a Private company.

  • What is the current valuation of Adriakaim?

    The current valuation of Adriakaim is .

  • What is Adriakaim’s current revenue?

    The current revenue for Adriakaim is .

  • How much funding has Adriakaim raised over time?

    Adriakaim has raised $15.4M.

  • Who are Adriakaim’s investors?

    Capital Medica Ventures, FLAG-41, Screen Holdings, 360ip Japan, and CEJ Capital are 5 of 9 investors who have invested in Adriakaim.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process